ID: ALA2207131

Max Phase: Preclinical

Molecular Formula: C11H13NO4

Molecular Weight: 223.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N[C@@H](Cc1ccccc1)C(=O)OCC(=O)O

Standard InChI:  InChI=1S/C11H13NO4/c12-9(11(15)16-7-10(13)14)6-8-4-2-1-3-5-8/h1-5,9H,6-7,12H2,(H,13,14)/t9-/m0/s1

Standard InChI Key:  GXNXKYLDEYCTMX-VIFPVBQESA-N

Associated Targets(Human)

Peptidyl-glycine alpha-amidating monooxygenase 90 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 223.23Molecular Weight (Monoisotopic): 223.0845AlogP: 0.18#Rotatable Bonds: 5
Polar Surface Area: 89.62Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.55CX Basic pKa: 6.97CX LogP: -1.55CX LogD: -2.05
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.70Np Likeness Score: 0.11

References

1. Morris KM, Cao F, Onagi H, Altamore TM, Gamble AB, Easton CJ..  (2012)  Prohormone-substrate peptide sequence recognition by peptidylglycine α-amidating monooxygenase and its reflection in increased glycolate inhibitor potency.,  22  (23): [PMID:23084901] [10.1016/j.bmcl.2012.10.004]

Source